Dr. Christopher Baker joined the Max Planck Florida Institute for Neuroscience in 2012 as a Research Scientist. His work includes neural circuit mapping, comparative genomics, and neuroanatomy in novel preclinical models of schizophrenia and autism. A main focus of Chris’s research is combining optogenetics and two photon microscopy to map neural circuits at single cell resolution in animal models of psychiatric disease.
Prior to joining Max Planck Florida Institute for Neuroscience, Chris spent 7 years at Scripps Florida where he studied genetic and epigenetic factors mediating susceptibility to prion infection in cultured cells. Chris received his PhD from Yale University in 2004. His graduate work was focused on microglial gene expression and infectivity in experimental Creutzfeldt-Jakob disease.